C-VXCYHerophilus (prev System 1 Bio)
brain organoids, scaled biology, machine learning
discoverydiscoveringsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-VXCY
C-VXCYC-VXCYbrain organoids, scaled biology, machine learning
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Herophilus (prev System 1 Bio) brain organoids, scaled biology, machine learning
Herophilus is reinventing neuro drug discovery to cure complex brain diseases. The company combines human brain models, scaled biology, and machine learning to discover and develop novel drugs with greater therapeutic potential. The site describes cerebral, cortical, ventral forebrain, and astrocyte-rich organoid systems used to study neuronal zones, synapses, neuropil, and disease biology.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Herophilus (prev System 1 Bio) — Early mechanism · Bottom quartile. Derived deterministically from 8 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic